This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: London Health Sciences Centre Research Inc.. Active years: 2022.
Company Filing History:
Years Active: 2022
Title: Lisa Fischer: Innovator in Metabolomics Profiling for CNS Injuries
Introduction
Lisa Fischer is a prominent inventor based in London, Canada. She has made significant contributions to the field of medical diagnostics, particularly in the area of central nervous system (CNS) injuries. Her innovative approach utilizes metabolomics to enhance the diagnosis of various CNS injuries, including acquired brain injury and spinal cord injury.
Latest Patents
Lisa Fischer holds a patent for her groundbreaking work titled "Metabolomics profiling of central nervous system injury." This patent outlines a method for diagnosing CNS injuries such as acquired brain injury (ABI) and acquired spinal cord injury (ASI). The method involves obtaining a biological test sample from the subject and identifying metabolites using metabolomics to generate a subject's metabolite matrix. By employing multivariate statistical analysis and machine learning, the method compares the subject's profile with predetermined profiles of CNS injuries and controls to determine the presence of a CNS injury. This patent represents a significant advancement in the diagnostic capabilities for CNS injuries, with Lisa Fischer being the sole inventor of this innovative method.
Career Highlights
Lisa Fischer is affiliated with the London Health Sciences Centre Research Inc., where she continues to work on advancing research in the field of metabolomics and CNS injuries. Her dedication to improving diagnostic methods has positioned her as a key figure in her field. With her innovative approach, she aims to enhance the accuracy and efficiency of diagnosing CNS injuries, ultimately benefiting patients and healthcare providers alike.
Collaborations
Throughout her career, Lisa has collaborated with esteemed colleagues such as Timothy Doherty and Gregory A Dekaban. These collaborations have further enriched her research and contributed to the development of her innovative diagnostic methods.
Conclusion
Lisa Fischer's contributions to the field of metabolomics and CNS injury diagnostics are noteworthy. Her patented method represents a significant step forward in medical diagnostics, showcasing her commitment to innovation and improving patient outcomes. Through her work, she continues to inspire advancements in the medical field.